CONFIDENTIALRosetta Genomics Ltd. • January 14th, 2010 • Pharmaceutical preparations • New York
Company FiledJanuary 14th, 2010 Industry Jurisdiction
ORDINARY SHARES PURCHASE WARRANT ROSETTA GENOMICS LTD.Rosetta Genomics Ltd. • January 14th, 2010 • Pharmaceutical preparations
Company FiledJanuary 14th, 2010 IndustryTHIS ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January __, 2010 (the “Initial Exercise Date”) and on or prior to the close of business on January __, 2015 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), up to ______ (the “Warrant Shares”) of the Company’s Ordinary Shares, NIS 0.01 par value per share (the “Ordinary Shares”) at the Exercise Price per Ordinary Share as set forth in Section 2(b) below.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 14th, 2010 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 14th, 2010 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 13, 2010, between Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).